Rate of APC mosaicism 9.4%. »
02/12/25

Findings emphasise need for improved clinical services. »
03/05/26

ABU did not significantly affect BCG immunotherapy outcomes. »
10/31/25

Stratification Of CLL By ZAP-70 Expression: Analysis Of Samples From The ECOG-Led Intergroup Trial E2997 »
02/03/14

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL) »
02/03/14

T-Cell Dysfunction In CLL Is Also Mediated By PD-1/PD-L2 Interactions -- Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment »
02/03/14

The Addition Of Sirolimus To The Gvhd Prophylaxis Regimen In Reduced Intensity Allogeneic Stem Cell Transplantation For Lymphoma: A Multicenter Randomized Trial »
02/22/14

Outcomes Of Chronic Lymphocytic Leukemia Patients With Richter Syndrome »
02/23/14

Signal Transducer and Activator Of Transcription 3 Activates and Deregulates Micro RNA Expression In Chronic Lymphocytic Leukemia Cells »
02/23/14

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkina€™s Lymphoma In The Womena€™s Health Initiative Cohort »
02/23/14